What sector does 3B Blackbio Dx Ltd. belong to?

3B Blackbio Dx Ltd. operates in the Healthcare sector, specifically the Healthcare Service Provider industry, and is listed on the NSE.

What is the current share price of 3BBLACKBIO?

As of the latest available quote, 3BBLACKBIO traded at ₹1,419.90. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 3BBLACKBIO?

3B Blackbio Dx Ltd. has a price-to-earnings (P/E) ratio of about 21.41. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 3BBLACKBIO?

The market capitalisation of 3B Blackbio Dx Ltd. is approximately ₹1,219 Cr.

Is 3B Blackbio Dx Ltd. profitable?

For its latest reported financial year, 3B Blackbio Dx Ltd. recorded a net profit margin of about 42.25%.

Does 3BBLACKBIO pay a dividend?

3B Blackbio Dx Ltd. does not currently show a dividend yield in our data.

What is the return on equity (ROE) of 3BBLACKBIO?

3B Blackbio Dx Ltd. has a return on equity (ROE) of about 19.80%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 3BBLACKBIO?

Over the past 52 weeks, 3BBLACKBIO has traded between a low of ₹1,099.50 and a high of ₹1,588.90.

3B Blackbio Dx Ltd.

3BBLACKBIO NSE Healthcare Healthcare Service Provider

₹1,419.90

-1.62%

Delayed · cached 15 min

Fair value analysis

3BBLACKBIO

3B Blackbio Dx Ltd.

₹1,443.30

Close used for this calculation

₹1,602.47Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

67/100

Profitability25/25

Returns11/25

Balance Sheet21/25

Efficiency10/25

Growth17/25

Strong

Quality radar

Consensus fair value

₹1,602.47

Near FV

▲ +11.0% against the close used

Model range ₹634.54 – ₹3,074.59

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹634.54Fair value₹1,602.47Bull₹3,074.59

FairClose

52-week traded range

52W low ₹1,143.8052W high ₹1,523.50

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

3B Blackbio Dx Ltd. closed at ₹1,443.30, 9.9% below the consensus fair value of ₹1,602.47 drawn from 9 valuation models.

Financial DNA score 67/100 — Strong. P/E of 22.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹634.54

-56.0%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹747.29

-48.2%

√(22.5 × EPS × BVPS)

EPS=68.27, BVPS=363.55 · outside Graham range (P/E 22, P/B 4) — asset-light, treat as a rough floor

Graham Formula

₹3,074.59

+113.0%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹2,870.75

+98.9%

EPS × 42.05x (sector P/E)

EPS=68.27, Sector P/E=42.05x

Peter Lynch (PEG)

₹1,706.75

+18.3%

EPS × Growth% (PEG = 1 is fair)

EPS=68.27, g=25%

EV/EBITDA

₹1,317.80

-8.7%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=620M

Book Value (P/B)

₹1,254.25

-13.1%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=363.55, ROE=19.8%, g=6%, r=10%

Reverse DCF

₹1,443.30

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 7.9% | Historical: 25%

Margin of Safety

₹1,373.84

-4.8%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=1831.79, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer